Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Starlite/ChEMBL | References |
Homo sapiens | nuclear receptor subfamily 3, group C, member 2 | Starlite/ChEMBL | References |
Homo sapiens | progesterone receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable 1-deoxy-D-xylulose 5-phosphate reductoisomerase Dxr (DXP reductoisomerase) (1-deoxyxylulose-5-phosphate reductoisomeras | 0.0428 | 0 | 0.5 |
Plasmodium falciparum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1782 | 1 | 0.5 |
Mycobacterium ulcerans | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1782 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1782 | 1 | 0.5 |
Treponema pallidum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.1782 | 1 | 0.5 |
Toxoplasma gondii | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.1782 | 1 | 0.5 |
Plasmodium vivax | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.1782 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE DXR (DXP REDUCTOISOMERASE) (1-DEOXYXYLULOSE-5-PHOSPHATE REDUCTOISOMERAS | 0.1782 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Efficacy (functional) | = 25 % | Inhibition of IL1-stimulated IL6 production in HFF cells relative to dexamethasone | ChEMBL. | 17181172 |
Efficacy (functional) | = 25 % | Inhibition of IL1-stimulated IL6 production in HFF cells relative to dexamethasone | ChEMBL. | 17181172 |
IC50 (binding) | = 15 nM | Inhibition of tetramethylrhodamine labeled dexamethosone binding to GR by FP assay | ChEMBL. | 17181172 |
IC50 (binding) | = 15 nM | Inhibition of tetramethylrhodamine labeled dexamethosone binding to GR by FP assay | ChEMBL. | 17181172 |
IC50 (binding) | = 310 nM | Inhibition of tetramethylrhodamine labeled dexamethosone binding to MR by FP assay | ChEMBL. | 17181172 |
IC50 (binding) | = 310 nM | Inhibition of tetramethylrhodamine labeled dexamethosone binding to MR by FP assay | ChEMBL. | 17181172 |
IC50 (functional) | = 600 nM | Inhibition of IL1-stimulated IL6 production in HFF cells | ChEMBL. | 17181172 |
IC50 (functional) | = 600 nM | Inhibition of IL1-stimulated IL6 production in HFF cells | ChEMBL. | 17181172 |
IC50 (binding) | = 640 nM | Inhibition of tetramethylrhodamine labeled RU486 binding to PR by FP assay | ChEMBL. | 17181172 |
IC50 (binding) | = 640 nM | Inhibition of tetramethylrhodamine labeled RU486 binding to PR by FP assay | ChEMBL. | 17181172 |
Ratio IC50 (binding) | < 50 | Ratio of IC50 for GR to PR | ChEMBL. | 17181172 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 17181172 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.